IL149533A0 - Treatment of sle with dehydropiandrosterone - Google Patents
Treatment of sle with dehydropiandrosteroneInfo
- Publication number
- IL149533A0 IL149533A0 IL14953300A IL14953300A IL149533A0 IL 149533 A0 IL149533 A0 IL 149533A0 IL 14953300 A IL14953300 A IL 14953300A IL 14953300 A IL14953300 A IL 14953300A IL 149533 A0 IL149533 A0 IL 149533A0
- Authority
- IL
- Israel
- Prior art keywords
- dehydropiandrosterone
- sle
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16510899P | 1999-11-12 | 1999-11-12 | |
US09/710,754 US6552010B1 (en) | 1999-11-12 | 2000-11-10 | Treatment of SLE with dehydroepiandrosterone |
PCT/US2000/030130 WO2001035949A2 (en) | 1999-11-12 | 2000-11-13 | Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
Publications (1)
Publication Number | Publication Date |
---|---|
IL149533A0 true IL149533A0 (en) | 2002-11-10 |
Family
ID=26861117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14953300A IL149533A0 (en) | 1999-11-12 | 2000-11-13 | Treatment of sle with dehydropiandrosterone |
Country Status (13)
Country | Link |
---|---|
US (2) | US6552010B1 (zh) |
EP (1) | EP1231924A2 (zh) |
JP (1) | JP2003514016A (zh) |
KR (1) | KR20020068344A (zh) |
CN (1) | CN1409635A (zh) |
AU (1) | AU784190B2 (zh) |
BR (1) | BR0015531A (zh) |
CA (1) | CA2388705A1 (zh) |
IL (1) | IL149533A0 (zh) |
MX (1) | MXPA02004777A (zh) |
NO (1) | NO20022244L (zh) |
RU (1) | RU2248207C2 (zh) |
WO (1) | WO2001035949A2 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050014734A1 (en) * | 2003-07-18 | 2005-01-20 | Genovate Biotechnology Co., Ltd. | Modulation of interleukin-10 by DHEA |
US8084444B2 (en) * | 2004-09-24 | 2011-12-27 | Rxdino, Llc | Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations |
US20100204192A1 (en) * | 2007-06-11 | 2010-08-12 | University Of Sourthern California | Agents, compositions and methods for enhancing neurological function |
US8969329B2 (en) * | 2007-06-11 | 2015-03-03 | University Of Southern California | Allopregnanolone in a method for enhancing neurological function |
RS60558B1 (sr) | 2015-08-11 | 2020-08-31 | Galera Labs Llc | Pentaaza makrociklični prstenasti kompleksi koji poseduju oralnu bioraspoloživost |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994008589A1 (en) | 1992-10-09 | 1994-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
EP1778246A2 (en) | 1999-03-18 | 2007-05-02 | Genelabs Technologies, Inc. | Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
-
2000
- 2000-11-10 US US09/710,754 patent/US6552010B1/en not_active Expired - Fee Related
- 2000-11-13 KR KR1020027006102A patent/KR20020068344A/ko not_active Application Discontinuation
- 2000-11-13 IL IL14953300A patent/IL149533A0/xx unknown
- 2000-11-13 MX MXPA02004777A patent/MXPA02004777A/es unknown
- 2000-11-13 RU RU2002115814/14A patent/RU2248207C2/ru not_active IP Right Cessation
- 2000-11-13 AU AU17543/01A patent/AU784190B2/en not_active Ceased
- 2000-11-13 CA CA002388705A patent/CA2388705A1/en not_active Abandoned
- 2000-11-13 JP JP2001537942A patent/JP2003514016A/ja not_active Withdrawn
- 2000-11-13 EP EP00980257A patent/EP1231924A2/en not_active Withdrawn
- 2000-11-13 WO PCT/US2000/030130 patent/WO2001035949A2/en not_active Application Discontinuation
- 2000-11-13 BR BR0015531-4A patent/BR0015531A/pt not_active IP Right Cessation
- 2000-11-13 CN CN00817002A patent/CN1409635A/zh active Pending
-
2002
- 2002-05-10 NO NO20022244A patent/NO20022244L/no not_active Application Discontinuation
-
2003
- 2003-01-08 US US10/340,267 patent/US20030181435A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2002115814A (ru) | 2004-03-10 |
JP2003514016A (ja) | 2003-04-15 |
US6552010B1 (en) | 2003-04-22 |
AU1754301A (en) | 2001-05-30 |
BR0015531A (pt) | 2002-12-31 |
RU2248207C2 (ru) | 2005-03-20 |
CA2388705A1 (en) | 2001-05-25 |
NO20022244D0 (no) | 2002-05-10 |
EP1231924A2 (en) | 2002-08-21 |
WO2001035949A2 (en) | 2001-05-25 |
US20030181435A1 (en) | 2003-09-25 |
AU784190B2 (en) | 2006-02-16 |
CN1409635A (zh) | 2003-04-09 |
NO20022244L (no) | 2002-07-03 |
MXPA02004777A (es) | 2003-01-28 |
WO2001035949A3 (en) | 2002-05-02 |
KR20020068344A (ko) | 2002-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1161893A1 (zh) | 煤炭加工 | |
PL355101A1 (en) | Use of h1 | |
GB9925136D0 (en) | Novel treatment | |
GB9805419D0 (en) | Treatment of liquids | |
HUP0200738A3 (en) | Method of the treatment of incontinence | |
PL349347A1 (en) | Novel treatment | |
IL149533A0 (en) | Treatment of sle with dehydropiandrosterone | |
EP1218407A4 (en) | USES OF KAPPA-CONOTOXIN PVIIA | |
PL350963A1 (en) | Use of arylalkanoylpyridazines | |
GB9904252D0 (en) | Composition for the treatment of pain | |
GB2356643B (en) | Woven-fabric treatment | |
GB0010496D0 (en) | Treatment of conditions of the central nervous system | |
GB9929981D0 (en) | The treatment of convulsive states | |
GB9901310D0 (en) | Methods of treatment | |
GB9917181D0 (en) | Methods of treatment | |
GB9910545D0 (en) | The treatment of acarids | |
GB9800707D0 (en) | Methods of treatment | |
GB9822458D0 (en) | Methods of treatment | |
GB9824208D0 (en) | Methods of treatment | |
GB9908993D0 (en) | Treatment | |
GB9824791D0 (en) | Novel methods of treatment | |
GB9920787D0 (en) | Novel treatment | |
GB9920788D0 (en) | Novel treatment | |
GB9909650D0 (en) | Novel treatment | |
GB9916655D0 (en) | Novel treatment |